RPRX - CIK 0001802768
The table below shows Royalty Pharma plc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $586.39M | $938.94M | $631.91M | $1.09B | $950.05M | $1.76B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.43B |
| $1.85B |
| $1.52B |
| $1.84B |
| $1.79B |
| $2.58B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $924.63M | $924.63M | $924.63M | - | - | - |
| Total assets | $19.82B | $19.35B | $18.32B | $17.61B | $18.04B | $17.66B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $535.68M | $530.80M | $1.21B | $1.18B | $1.17B | $275.70M |
| Long-term debt | $8.58B | $8.57B | $7.00B | $6.62B | $6.61B | $7.60B |
| Total liabilities | $9.88B | $9.73B | $8.82B | $7.82B | $7.78B | $7.90B |
| Retained earnings | $2.51B | $2.30B | $2.22B | $2.48B | $2.76B | $2.38B |
| Total equity | - | - | - | - | - | - |